Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

SHE:301166 Revenue

Shanghai Universal Biotech had revenue of 259.31M CNY in the quarter ending March 31, 2026, with 19.85% growth. This brings the company's revenue in the last twelve months to 1.13B, up 6.04% year-over-year. In the year 2025, Shanghai Universal Biotech had annual revenue of 1.08B, down -3.05%.

• Revenue (ttm): 1.13B
• Revenue Growth: +6.04%
• P/S Ratio: 2.12
• Revenue / Employee: 1.39M
• Employees: 810
• Market Cap: 2.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.08B	-34.05M	-3.05%
Dec 31, 2024	1.12B	-108.07M	-8.82%
Dec 31, 2023	1.23B	30.70M	2.57%
Jan 1, 2023	1.20B	85.46M	7.70%
Jan 1, 2022	1.11B	260.59M	30.69%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error